Tegileridine: First Approval (vol 84, pg 717, 2024)

被引：0

作者：

Dhillon, Sohita ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-024-02079-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1011 / 1011

页数：1

共 50 条

[21] Contezolid: First Approval (vol 81, pg 1587, 2021)
Hoy, Sheridan M.
DRUGS, 2021, 81 (16) : 1945 - 1945
[22] Concizumab: First Approval (vol 83, pg 1053, 2023)
Keam, Susan J.
DRUGS, 2023, 83 (13) : 1253 - 1254
[23] Oliceridine: First Approval (vol 80, pg 1739, 2020)
Markham, Anthony
DRUGS, 2020, 80 (17) : 1871 - 1871
[24] Lonafarnib: First Approval (vol 81, pg 283, 2020)
Dhillon, Sohita
DRUGS, 2021, 81 (05) : 619 - 619
[25] Ritlecitinib: First Approval (vol 83, pg 1315, 2023)
Blair, Hannah A.
DRUGS, 2023, 83 (15) : 1457 - 1457
[26] Selpercatinib: First Approval (vol 80, pg 1119, 2020)
Markham, Anthony
DRUGS, 2021, 81 (01) : 181 - 181
[27] Lenacapavir: First Approval (vol 82, pg 1499, 2022)
Paik, Julia
DRUGS, 2023, 83 (11) : 1061 - 1061
[28] Nedosiran: First Approval (vol 83, pg 1729, 2023)
Syed, Yahiya Y.
DRUGS, 2024, 84 (02) : 219 - 226
[29] Abrocitinib: First Approval (vol 81, pg 2149, 2021)
Deeks, Emma D.
Duggan, Sean
DRUGS, 2022, 82 (05) : 609 - 609
[30] Infigratinib: First Approval (vol 81, pg 1355, 2021)
Kang, Connie
DRUGS, 2022, 82 (01) : 93 - 93